Immunohistochemical analysis showed that both amyloid beta 1–42 and p-tau were abundantly expressed in untreated 3xTg-AD mice, while their expression was greatly attenuated after treatment of the animals with the anti-TNFSF10 antibody (Fig. 8). Here, MAPT is linked to Alzheimer disease.